These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11074526)

  • 1. Growth-inhibitory activity of melatonin on human androgen-independent DU 145 prostate cancer cells.
    Marelli MM; Limonta P; Maggi R; Motta M; Moretti RM
    Prostate; 2000 Nov; 45(3):238-44. PubMed ID: 11074526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiproliferative action of melatonin on human prostate cancer LNCaP cells.
    Moretti RM; Marelli MM; Maggi R; Dondi D; Motta M; Limonta P
    Oncol Rep; 2000; 7(2):347-51. PubMed ID: 10671684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the orphan nuclear receptor RORalpha induces growth arrest in androgen-independent DU 145 prostate cancer cells.
    Moretti RM; Marelli MM; Motta M; Polizzi D; Monestiroli S; Pratesi G; Limonta P
    Prostate; 2001 Mar; 46(4):327-35. PubMed ID: 11241556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of androgen-sensitive LNCaP prostate cancer growth in vivo by melatonin: association of antiproliferative action of the pineal hormone with mt1 receptor protein expression.
    Xi SC; Siu SW; Fong SW; Shiu SY
    Prostate; 2001 Jan; 46(1):52-61. PubMed ID: 11170132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential involvement of mt1 receptor and attenuated sex steroid-induced calcium influx in the direct anti-proliferative action of melatonin on androgen-responsive LNCaP human prostate cancer cells.
    Xi SC; Tam PC; Brown GM; Pang SF; Shiu SY
    J Pineal Res; 2000 Oct; 29(3):172-83. PubMed ID: 11034115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity.
    Siu SW; Lau KW; Tam PC; Shiu SY
    Prostate; 2002 Jul; 52(2):106-22. PubMed ID: 12111702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiproliferative effects of luteinizing hormone-releasing hormone (LHRH) agonists on human androgen-independent prostate cancer cell line DU 145: evidence for an autocrine-inhibitory LHRH loop.
    Dondi D; Limonta P; Moretti RM; Marelli MM; Garattini E; Motta M
    Cancer Res; 1994 Aug; 54(15):4091-5. PubMed ID: 8033142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of malignant trophoblastic cell proliferation in vitro and in vivo by melatonin.
    Shiu SY; Xi SC; Xu JN; Mei L; Pang SF; Yao KM; Wong JT
    Life Sci; 2000 Sep; 67(17):2059-74. PubMed ID: 11057756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melatonin-induced inhibition of proliferation and G1/S cell cycle transition delay of human choriocarcinoma JAr cells: possible involvement of MT2 (MEL1B) receptor.
    Shiu SY; Li L; Xu JN; Pang CS; Wong JT; Pang SF
    J Pineal Res; 1999 Oct; 27(3):183-92. PubMed ID: 10535768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of melatonin MT(1) and MT(2) receptors, and ROR alpha(1) receptor in transplantable murine Colon 38 cancer.
    Karasek M; Carrillo-Vico A; Guerrero JM; Winczyk K; Pawlikowski M
    Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():55-60. PubMed ID: 12019353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncostatic activity of a thiazolidinedione derivative on human androgen-dependent prostate cancer cells.
    Moretti RM; Montagnani Marelli M; Motta M; Limonta P
    Int J Cancer; 2001 Jun; 92(5):733-7. PubMed ID: 11340580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
    Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
    Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin elicits nuclear exclusion of the human androgen receptor and attenuates its activity.
    Rimler A; Culig Z; Levy-Rimler G; Lupowitz Z; Klocker H; Matzkin H; Bartsch G; Zisapel N
    Prostate; 2001 Oct; 49(2):145-54. PubMed ID: 11582594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional melatonin receptors in rat ovaries at various stages of the estrous cycle.
    Soares JM; Masana MI; Erşahin C; Dubocovich ML
    J Pharmacol Exp Ther; 2003 Aug; 306(2):694-702. PubMed ID: 12721330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mel 1a melatonin receptor expression is regulated by protein kinase C and an additional pathway addressed by the protein kinase C inhibitor Ro 31-8220 in ovine pars tuberalis cells.
    Barrett P; Davidson G; Hazlerigg DG; Morris MA; Ross AW; Morgan PJ
    Endocrinology; 1998 Jan; 139(1):163-71. PubMed ID: 9421411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin reduces prostate cancer cell growth leading to neuroendocrine differentiation via a receptor and PKA independent mechanism.
    Sainz RM; Mayo JC; Tan DX; León J; Manchester L; Reiter RJ
    Prostate; 2005 Apr; 63(1):29-43. PubMed ID: 15378522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the Mel 1a melatonin receptor mRNA and protein levels in the ovine pars tuberalis: evidence for a cyclic adenosine 3',5'-monophosphate-independent Mel 1a receptor coupling and an autoregulatory mechanism of expression.
    Barrett P; MacLean A; Davidson G; Morgan PJ
    Mol Endocrinol; 1996 Jul; 10(7):892-902. PubMed ID: 8813729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of ghrelin and biological activity of specific receptors for ghrelin and des-acyl ghrelin in human prostate neoplasms and related cell lines.
    Cassoni P; Ghé C; Marrocco T; Tarabra E; Allia E; Catapano F; Deghenghi R; Ghigo E; Papotti M; Muccioli G
    Eur J Endocrinol; 2004 Feb; 150(2):173-84. PubMed ID: 14763915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the orphan nuclear receptor RORalpha counteracts the proliferative effect of fatty acids on prostate cancer cells: crucial role of 5-lipoxygenase.
    Moretti RM; Montagnani Marelli M; Sala A; Motta M; Limonta P
    Int J Cancer; 2004 Oct; 112(1):87-93. PubMed ID: 15305379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation by melatonin of cell growth and androgen receptor binding to the androgen response element in prostate cancer cells.
    Rimler A; Lupowitz Z; Zisapel N
    Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():45-9. PubMed ID: 12019351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.